CME Program Detail...
2024 Stroke & Neurocritical Care Symposium
Date: Wed, Nov 13th, 2024
Time: 2:00 pm - 5:45 pm
Location: Lang Auditorium
Statement of Need:
Neurological disorders affect millions of Americans each year, with stroke being a leading cause of morbidity and mortality, especially in an aging population. To offer patients the most effective treatment options, it is essential that physicians and the interdisciplinary healthcare team remain updated on the latest advancements in medical and surgical treatments for neurological diseases.
Target Audience:
Primary care physicians, neurologists, ER physicians, residents, fellows, interns, medical students, physician assistants, nurse practitioners, registered nurses and others caring for patients with neurological conditions.
Baxter B. Allen, M.D.
Assistant Professor of Clinical Neurology
Weill Cornell Medicine
Director of Stroke Services
Attending Neurologist and Neurointensivist
NewYork-Presbyterian Queens
Ning Lin, M.D.
Associate Professor of Neurosurgery
Weill Cornell Medicine
Attending Neurosurgeon, Department of Surgery
NewYork-Presbyterian Queens
Srikanth R. Boddu, M.D.
Associate Professor of Radiology in Clinical Neurological Surgery
Weill Cornell Medicine
Director of Neurointervention
Department of Neurological Surgery
NewYork-Presbyterian Queens
Nasim A. Chowdhury, M.D., FAAPMR, CNT
Assistant Professor of Clinical Rehabilitation
Weill Cornell Medicine
Adjunct Professor of Rehabilitation & Regenerative Medicine
Columbia University Vagelos College of Physicians & Surgeons
Chief of Rehabilitation Medicine
NewYork-Presbyterian Queens
Katharine Dermigny, M.D.
Assistant Professor of Clinical Neurology
Weill Cornell Medicine
Attending Neurologist
NewYork-Presbyterian Queens
Kenneth Han, M.D.
Assistant Professor of Clinical Neurology
Weill Cornell Medicine
Attending Neurologist
NewYork-Presbyterian Queens
Jared Knopman, M.D.
Associate Professor of Neurological Surgery
Weill Cornell Medicine
Attending Neurosurgeon & Interventional Neuroradiologist
NYP/Weill Cornell Medical Center
Shamelia Y. Loiseau, M.D.
Assistant Professor of Clinical Neurology
Weill Cornell Medicine
Attending Neurointensivist
NewYork-Presbyterian Queens
Alexander E. Merkler, M.D., MS
Assistant Professor of Neurology & Neuroscience
Director, NYP Tele-NeuroICU Service
Site Director, NYP Neurocritical Care Fellowship
Weill Cornell Medicine
Santosh Murthy, M.D., MPH, FNCS, FANA
Associate Professor of Neurology & Neuroscience
Weill Cornell Medicine
Associate Chief; Director of Research
Division of Neurocritical Care
NYP/Weill Cornell Medical Center
Melvin Parasram, D.O., MS
Assistant Professor of Clinical Neurology
Weill Cornell Medicine
Attending Neurologist
NewYork-Presbyterian Queens
Jay Yasen, M.D., FAAN
Assistant Professor of Clinical Neurology
Weill Cornell Medicine
Attending Neurologist
NewYork-Presbyterian Queens
Disclosures: Dr. Kenneth Han is a Consultant for Epitel, Inc.
Dr. Jared Knapman is a Sponsor of Trial, Consultant, Steering Committee for Medtronic; Consultant for Balt, Phenox, Kaneka; Medical Advisory Board & Consultant for Stryker
Dr. Alexander Merkler – *Medicolegal Consulting *Relationship Ended
Dr. Santosh Murthy – Grant Support from NIH/NINDS; Medicolegal Consulting in stroke and neurological disorders
All relevant relationships have been mitigated.
All of the other planners and faculty participants do not have any financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in these materials.
Ning Lin, M.D. and Baxter B. Allen, M.D.
**PT/PTA CEUs: maximum of 10 contact hours
• Through targeted prevention and early intervention strategies learned to reduce the incidence of stroke related to respiratory infections.
• Closely monitor blood pressure after mechanical thrombectomy.
• Implement current recommendations for managing specific conditions to improve patient outcomes.
• Select tailored therapeutic agents for patients with status epilepticus, based on individual patient characteristics and the underlying cause of seizures.
• Distinguish the diagnostic tools and treatment strategies for dural arteriovenous fistulas.
• Evaluate how dural arteriovenous fistulas present in patients and how the condition develops or change if left untreated.
• Analyze the risks and benefits of starting antiplatelet and anticoagulation therapies after intracerebral hemorrhage.
• Analyze the various stroke rehabilitation techniques and select the most appropriate approach based on individual patient characteristics to optimize patient outcomes
• Facilitate more informative and transparent goals-of-care discussions with families regarding the limitations and possibilities of clinically predicting functional outcomes after severe TBI.
This educational program will cover critical topics, including:
• Stroke risks associated with COVID-19 and other respiratory viruses
• Stroke risk reduction with modern weight loss medications
• Stroke rehabilitation techniques
• Medical management of ischemic and hemorrhagic strokes
• Controversies in stroke intervention
• Management of cerebral dural arteriovenous fistulas
• Idiopathic intracranial hypertension
• Minimally invasive management of subdural hematoma
• Traumatic brain injury management and recent clinical trials
• Seizure management in the Neuro-Intensive Care Unit
• Brain death examination protocols
Each session will be followed by a Q&A, allowing for interactive discussions with the audience. By providing in-depth education on these neurological conditions and the latest management strategies, this program will equip healthcare providers the skills to plan more effective treatment approaches, ultimately leading to better patient outcomes.
Wednesday, November 13, 2024 (Day 1)
2:00PM Opening Remarks
Section 1: Before and After Strokes: Risk Prevention and Maximize Recovery
2:05 PM Flu, COVID & Other Respiratory Virus and Stroke Risks
Alexander E. Merkler, M.D., MS
2:40 PM Stroke and Cardiovascular Risks and New Generation of Weight Loss Drugs
Katharine Dermigny, M.D.
3:20 PM Stroke Rehabilitation and VNS-REHAB Trial
Nasim A. Chowdhury, M.D., FAAPMR, CNT
4:00 PM Questions & Answers
Section 2: The Known and Unknown: Controversies in Stroke and Neuro-Critical Care Management
4:10 PM Medical Management of ICH/Anticoagulation/APT Restart Time
Santosh Murthy, M.D., MPH, FNCS, FANA
4:50 PM Blood Pressure and Hemodynamic Management for Intracranial Large Vessel Occlusion
Baxter B. Allen, M.D.
5:30 PM Overview of Thrombolysis and Thrombectomy for Acute Ischemic Stroke and Controversies
Jay Yasen, M.D.
6:10 PM Questions and Answers
6:30 PM Adjourn
Thursday, November 14, 2024 (Day 2)
2:00PM Opening Remarks
Section 3: The Interventions: Surgical and Endovascular Procedures for Critically Ill Patients
2:05 PM Various Types of Cranial Fistulas & Their Management
Ning Lin, M.D.
2:40 PM Cerebral Venous Interventions for Pulsatile Tinnitus & IIH
Srikanth R. Boddu, M.D.
**3:20 PM Management of Subdural Hematoma and EMBOLISE Trial
Jared Knopman, M.D. **NO CME AWARDED
4:00 PM Questions and Answers
Section 4: Critical Issues: Challenges in the Neuroscience ICU
4:10 PM Traumatic Brain Injury and BOOST Trial
Shamelia Y. Loiseau, M.D.
4:50 PM The Brain Death Examination
Melvin Parasram, D.O., MS
5:30 PM Management of Status Epilepticus in the Neurocritical Care Unit
Kenneth Han, M.D.
6:10 PM Questions and Answers
6:30 PM Adjourn
Accreditation
NewYork Presbyterian/Queens is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.
NewYork Presbyterian/Queens designates this Live Activity for a maximum of 7.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
The Medical Society of The State of New York relies upon planners and faculty participants in its CME activities to provide educational information that is objective and free of bias. In this spirit and in accordance with the guidelines of MSSNY, CPME and the ACCME, all speakers and planners for CME activities must disclose any relevant financial relationships with
commercial interests whose products, devices or services may be discussed in the content of a CME activity, that might be perceived as a real or apparent conflict of interest. Any discussion of investigational or unlabeled uses of a product will be identified.
Symposium
Department: Neurology
Specialty: Neurology
CME Credit Hours: 7.50
Event Sponsors:
NYPQ CME
Doctor Fee: $50
Nurse Fee: $25
Other Attendee Fee: $25
